Holen Sie sich die Stockscreener-App
1.30
1.56%
0.02
Schlusskurs vom Vortag:
$1.28
Offen:
$1.27
24-Stunden-Volumen:
977.24K
Relative Volume:
0.38
Marktkapitalisierung:
$141.90M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-1.0569
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
+14.04%
1M Leistung:
-0.76%
6M Leistung:
-18.24%
1J Leistung:
-41.18%
1-Tages-Spanne:
$1.255
$1.31
1-Wochen-Bereich:
$1.11
$1.31
52-Wochen-Spanne:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.30 | 139.71M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-10-22 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-10-22 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Is Alector Inc a good long term investmentTrading Psychology Tips & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Alector principal accounting officer Wong-Sarad sells $5,751 in stock By Investing.com - Investing.com Nigeria
Alector principal accounting officer Wong-Sarad sells $5,751 in stock - Investing.com
Transcript : Alector, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 02 - marketscreener.com
Performance Recap: What valuation ratios show for Alector Inc 0Z2 stockStock Surge & Fast Entry Momentum Trade Alerts - BỘ NỘI VỤ
Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
How the Narrative Surrounding Alector Has Changed After the Latozinemab Trial Failure - Yahoo Finance
Will Alector Inc. (0Z2) stock announce special dividendTreasury Yields & AI Powered Market Entry Ideas - Newser
How supply shortages influence Alector Inc. (0Z2) stockQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
Arnon Rosenthal Sells 104,347 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
Sara Kenkare-Mitra Sells 41,687 Shares of Alector (NASDAQ:ALEC) Stock - MarketBeat
What valuation ratios show for Alector Inc. (0Z2) stockTrade Signal Summary & Daily Technical Forecast Reports - Newser
How Alector Inc. (0Z2) stock compares with top peersBreakout Watch & High Yield Stock Recommendations - Newser
Will Alector Inc. (0Z2) stock benefit from Fed rate cutsWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser
Alector CEO Rosenthal sells $116k in shares By Investing.com - Investing.com South Africa
Alector chief business officer sells $41,717 in stock By Investing.com - Investing.com South Africa
Alector principal accounting officer Wong-Sarad sells $9k in stock - Investing.com Canada
Alector: president Kenkare-Mitra sells $46k in shares By Investing.com - Investing.com Nigeria
Alector: president Kenkare-Mitra sells $46k in shares - Investing.com
Alector CEO Rosenthal sells $116k in shares - Investing.com
Alector chief business officer sells $41,717 in stock - Investing.com
Is Alector Inc. (0Z2) stock in buy zone after pullback2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Will Alector Inc. (0Z2) stock draw ESG focused fundsQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Is Alector Inc. (0Z2) stock supported by strong fundamentalsJuly 2025 Breakouts & Long-Term Safe Investment Ideas - Newser
Alector to Participate in the Bank of America CNS Therapeutics Conference - GlobeNewswire
Will Alector Inc. stock outperform tech sector in 2025Quarterly Profit Summary & Consistent Income Trade Ideas - BỘ NỘI VỤ
Alector (NASDAQ:ALEC) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
How rising interest rates impact Alector Inc. stockRate Cut & AI Optimized Trade Strategies - BỘ NỘI VỤ
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Investors to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Investors to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm - Caledonian Record
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Shareholders to Reach Out - ACCESS Newswire
Alector Inc (ALEC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Bronstein, Gewirtz & Grossman, LLC Encourages Alector, Inc. (ALEC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How Analysts See Alector’s Story Shifting After the Latest Clinical Setback - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Alector Inc. stock is in analyst buy zoneJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
What Wall Street predicts for Alector Inc. stock priceJuly 2025 Final Week & Proven Capital Preservation Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alector, Inc. (ALEC) And Encourages Stockholders to Reach Out - ACCESS Newswire
Is Alector Inc. (0Z2) stock a safe buy pre earnings2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):